Neuroone Medical Technologies (NMTC) Return on Assets (2011 - 2026)

Neuroone Medical Technologies' Return on Assets history runs 15 years deep, the most recent figure standing at 0.01% for Q1 2026.

• Quarterly Return on Assets changed 0.0% year-over-year to 0.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, up 1.0% from the prior year.
• Return on Assets was 0.01% for Q1 2026 at Neuroone Medical Technologies, down from 0.01% in the prior quarter.
• Across five years, Return on Assets topped out at 0.0% in Q3 2025 and bottomed at 0.02% in Q3 2024.
• A 5-year average of 0.01% and a median of 0.01% in 2024 frame the typical range for Return on Assets.
• Annual changes were most pronounced in 2022 — Return on Assets slipped 2 bps — and 2025, when it grew 2 bps.
• Neuroone Medical Technologies' Return on Assets stood at 0.01% in 2022, then sank by 144 bps to 0.02% in 2023, then soared by 37 bps to 0.01% in 2024, then soared by 42 bps to 0.01% in 2025, then dropped by 22 bps to 0.01% in 2026.
• Business Quant data shows NMTC's Return on Assets at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.0% in Q3 2025.